SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer - Quaterly Results

03 Feb 2022 Evaluate
The Revenue for the quarter ended  December 2021 of Rs. 6759.00 millions grew by 13.89 % from Rs. 5934.90 millions.Net profit for the quarter ended December 2021 increases to Rs. 1439.10  millions from Rs. 1412.40 millions.The company reported a good operating profit of 2134.30 millions compared to 2113.40 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 6759.00 5934.90 13.89 20613.30 17037.90 20.98 22385.50 21516.50 4.04
Other Income 182.60 145.70 25.33 455.30 439.20 3.67 811.20 1840.20 -55.92
PBIDT 2134.30 2113.40 0.99 7158.10 6303.00 13.57 7932.40 7565.80 4.85
Interest 21.80 38.50 -43.38 66.40 115.70 -42.61 151.10 108.50 39.26
PBDT 2112.50 2074.90 1.81 7091.70 6187.30 14.62 7781.30 7457.30 4.34
Depreciation 271.60 272.30 -0.26 813.90 821.00 -0.86 1094.10 1032.40 5.98
PBT 1840.90 1802.60 2.12 6277.80 5366.30 16.99 6687.20 6424.90 4.08
TAX 401.80 390.20 2.97 1410.10 1395.70 1.03 1711.10 1333.60 28.31
Deferred Tax -146.70 11.10 -1421.62 -263.90 -49.90 428.86 -125.20 1.60 -7925.00
PAT 1439.10 1412.40 1.89 4867.70 3970.60 22.59 4976.10 5091.30 -2.26
Equity 457.50 457.50 0.00 457.50 457.50 0.00 457.50 457.50 0.00
PBIDTM(%) 31.58 35.61 -11.32 34.73 36.99 -6.13 35.44 35.16 0.78

Pfizer Share Price

4767.40 68.60 (1.46%)
06-May-2026 09:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1821.40
Dr. Reddys Lab 1282.35
Cipla 1338.85
Zydus Lifesciences 919.50
Lupin 2369.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×